Genomic expression systems on hierarchy and network leading to hypertension: Long on history, short on facts

Hypertension Research

Volumn 23, Issue 6, 2000, Pages 545-552

  Fukamizu, A ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Angiotensin; Blood brain barrier; Genomedicine; Hypertension; Hypotension; Knockout mouse; Pregnancy induced hypertension; Renin angiotensin system; Transgenic mouse

Indexed keywords

ANGIOTENSIN; DNA; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD BRAIN BARRIER; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DNA SEQUENCE; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ENGINEERING; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; HYPERTENSION; HYPOTENSION; KNOCKOUT MOUSE; MATERNAL HYPERTENSION; MEDICAL GENETICS; MOUSE; MULTIFACTORIAL INHERITANCE; NONHUMAN; PATHOGENESIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SEQUENCE ANALYSIS; TRANSGENIC MOUSE;

EID: 0034535624     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.23.545     Document Type: Review

References (68)

1. Genetic and non-genetic basis of essential hypertension: Maladaptation of human civilization to high salt intake
2. Guidelines for hypertension in the elderly - 1999: Revised version
3. Genes and hypertension: From gene mapping in experimental models to vascular gene transfer strategies
4. Identifying candidate genes for blood pressure quantitative trait loci using differential gene expression and a panel of congenic strains
5. Use of transgenic animals in the study of neuropeptide genes
6. New aspects of the reninangiotensin system in blood pressure regulation
7. Cross talk between angiotensin II type 1 and type 2 receptors; cellular mechanism of angiotensin type 2 receptor-mediated cell growth inhibition
8. Angiotensin II receptor antagonists: An emerging new class of cardiovascular therapeutics
9. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases
10. The renin-angiotensin-aldosterone system: A specific target for hypertension management
11. Functional analysis of cardiovascular renin-angiotensin system using a gain or loss of function approach
12. Cosegregation of the renin allele of the spontaneously hypertensive rat with an increase in blood pressure
13. Molecular basis of human hypertension: Role of angiotensinogen
14. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension
15. Interrupting the renin-angiotensin system; the role of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of hypertension
16. Molecular genetics of human blood pressure variation
17. Tissue-specific expression of the human renin gene in transgenic mice
18. Expression of the human angiotensinogen gene in transgenic mice and transfected cells
19. Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes
20. Role of the renin-angiotensin system in cardiac hypertrophy and renal glomerular sclerosis in transgenic hypertensive mice carrying both human renin and angiotensinogen genes
21. Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen
22. A molecular variant of angiotensinogen associated with preeclampsia
23. Angiotensinogen: A candidate gene involved in preeclampsia?
24. Structure and expression of the human angiotensinogen gene: Identification of a unique and highly active promoter
25. Mouse model for pregnancy problem?
26. New insights into the genetics of preeclampsia
27. Is angiotensinogen gene polymorphism associated with hypertension in pregnancy?
28. Association of a variant of the angiotensinogen gene with pure type of hypertension in pregnancy in the Japanese: Implication of a racial difference and significance of an age factor
29. Using knockout and transgenic mice to study neurophysiology and behavior
30. Angiotensinogen-deficient mice with hypotension
31. Genetic control of blood pressure and the angiotensinogen locus
32. Male-female differences in fertility and blood pressure in ACE-deficient mice
33. Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility
34. Regulation of blood pressure by the type 1A angiotensin II receptor gene
35. Angiotensin II type 1a receptor-deficient mice with hypotension and hypereninemia
36. Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II
37. Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes
38. Renin-dependent cardiovascular functions and -independent brain functions revealed by renin-deficient mice
39. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice
40. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor
41. Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation
42. Pathologic characterization of hypotensive C57BL/6J-agt: Angiotensinogen-deficient C57BL/6J mice
43. Rescue of angiotensinogen-knockout mice
44. Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men
45. Angiotensin, thirst, and sodium appetite
46. Astrocytes synthesize angiotensinogen in brain
47. Astrocyte cultures derived from human brain tissue express angiotensinogen mRNA
48. The control of glial populations in brain: Changes in astrocyte mitogenic and morphogenic factors in response to injury
49. Astrocyte responses to CNS injury
50. Astrocytes induce blood-brain barrier properties in endothelial cells
51. Reaction of oligodendrocytes and astrocytes to trauma and implantation
52. Enhanced expression of the developmentally regulated extracellular matrix molecule tenasin following adult brain injury
53. Gliosis following CNS injury: The anatomy of astrocytic scars and their influences on avonal elongation
54. Impaired blood-brain barrier function in angiotensinogen-deficient mice
55. Protective effects of liposome-entrapped superoxide dismutase on post-traumatic brain edema
56. Role of endothelin-1 in astrocyte responses after acute brain damage
57. Angiotensin III and IV activation of the brain AT1 receptor subtype in cardiovascular function
58. The angiotensin IV system: Functional implications
59. Autoradiographic identification of brain angiotensin IV binding sites and differential c-Fos expression following intracere-broventricular injection of angiotensin II and IV in rats
60. Central angiotensin IV binding sites: Distribution and specificity in guinea pig brain
61. Distribution of AT4 receptors in the Macaca fascicularis brain
62. Expression of a novel angiotensin II receptor subtype in gerbil brain
63. Molecular advances in cardiovascular biology
64. Functional genomics in the post-genome era
65. Large scale ENU screens in the mouse: Genetics meets genomics
66. Genomics: Structural and functional studies of genomes
67. Functional genomics: It's all how you read it
68. Transcription-modulating drugs: A new frontier in the treatment of essential hypertension